NVIC

Pfizer – BioNTech mRNA COVID-19 Vaccine (Age 5 through 11 years)

Published November 10, 2021

In September 2023, the FDA issued an EUA for an updated Pfizer-BioNTech COVID-19 mRNA vaccine for use in children aged five through 11 years of age to target the Omicron variant XBB.1.5. 

The FDA initially authorized use of a 10-mcg dose of Pfizer-BioNTech mRNA COVID-19 vaccine to target the original SARS-CoV-2 strain for children 5 through 11 years of age in October 2021,  and an updated vaccine product containing the original SARS-CoV-2 variant and the Omicron BA.4/BA.5 variant in October 2022.  These previously authorized vaccine formulations are no longer available for use in the U.S. 

According to the Fact Sheet provided by the FDA, for 2023-2024, each 0.3 ml dose of Pfizer-BioNTech COVID-19 Vaccine contains 10mcg of nucleoside modified messenger RNA (mRNA) that encodes the pre-fusion stabilized Spike glycoprotein (S) of SARS-CoV-2 virus targeting the Omicron variant XBB.1.5. 

Each dose also contains a total lipid content of (0.14 mg (4- hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.03 mg 1,2-distearoyl-sn-glycero-3-phosphocholine, and 0.06 mg cholesterol), 0.02 mg 2[(polyethylene glycol)-2000- N,N-ditetradecylacetamide, 31 mg sucrose, 0.06 mg tromethamine, and 0.4 mg tromethamine hydrochloride. The vaccine also contains 0.9mg sodium chloride per dose. The vaccine vial stoppers are free of latex and the vaccine does not contain a preservative. 

The vaccine is recommended to be administered intramuscularly (IM). There is no data on the safety or effectiveness of administering the Pfizer-BioNTech COVID-19 vaccine with any other vaccine. 

Pfizer-BioNTech COVID-19 vaccine has not been studied for its potential to cause cancer, genotoxicity or male infertility. 

On September 12, 2023, the CDC’s ACIP voted to approve use of the 10mcg dose of the Pfizer-BioNTech 2023-2024 COVID-19 mRNA vaccine targeting the Omicron variant XBB.1.5 in all children 5 through 11 years of age. 

Select disease / vaccine